Morningstar Investment Services’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $6.08M | Sell |
13,982
-15,763
| -53% | -$6.33M | 1.11% | 19 |
|
|
2024
Q4 | $11M | Sell |
29,745
-218,026
| -88% | -$91.2M | 1% | 22 |
|
|
2024
Q3 | $130M | Sell |
247,771
-3,566
| -1% | -$1.91M | 1.32% | 17 |
|
|
2024
Q2 | $135M | Sell |
251,337
-1,159
| -0.5% | -$613K | 1.46% | 14 |
|
|
2024
Q1 | $131M | Sell |
252,496
-257,978
| -51% | -$128M | 1.44% | 15 |
|
|
2023
Q4 | $239M | Buy |
+510,474
| New | +$236M | 1.35% | 20 |
|
|
2022
Q2 | – | Sell |
-219,149
| Closed | -$109M | – | 221 |
|
|
2022
Q1 | $109M | Buy |
219,149
+3,475
| +2% | +$1.59M | 1.22% | 24 |
|
|
2021
Q4 | $100M | Buy |
215,674
+5,260
| +2% | +$2.21M | 1.11% | 26 |
|
|
2021
Q3 | $81.7M | Buy |
210,414
+4,111
| +2% | +$1.56M | 0.96% | 30 |
|
|
2021
Q2 | $78.7M | Buy |
206,303
+6,726
| +3% | +$2.57M | 0.94% | 32 |
|
|
2021
Q1 | $72.7M | Buy |
199,577
+382
| +0.2% | +$123K | 0.95% | 27 |
|
|
2020
Q4 | $64M | Buy |
199,195
+7,064
| +4% | +$2.17M | 0.89% | 30 |
|
|
2020
Q3 | $49.9M | Buy |
192,131
+7,771
| +4% | +$2.09M | 0.77% | 34 |
|
|
2020
Q2 | $47.8M | Buy |
184,360
+8,781
| +5% | +$2.34M | 0.79% | 35 |
|
|
2020
Q1 | $40.5M | Buy |
175,579
+6,789
| +4% | +$1.85M | 0.74% | 37 |
|
|
2019
Q4 | $51M | Buy |
168,790
+7,808
| +5% | +$2.15M | 0.8% | 33 |
|
|
2019
Q3 | $38.6M | Buy |
160,982
+7,453
| +5% | +$2.04M | 0.65% | 44 |
|
|
2019
Q2 | $43.3M | Buy |
153,529
+75,540
| +97% | +$20.6M | 0.71% | 35 |
|
|
2019
Q1 | $22.4M | Buy |
77,989
+965
| +1% | +$279K | 0.38% | 81 |
|
|
2018
Q4 | $20.2M | Buy |
77,024
+2,786
| +4% | +$766K | 0.4% | 77 |
|
|
2018
Q3 | $20.3M | Sell |
74,238
-944
| -1% | -$245K | 0.37% | 81 |
|
|
2018
Q2 | $17.9M | Buy |
75,182
+3,480
| +5% | +$806K | 0.34% | 85 |
|
|
2018
Q1 | $15.8M | Buy |
+71,702
| New | +$16.8M | 0.31% | 92 |
|
|
2015
Q3 | – | Sell |
-3,914
| Closed | -$642K | – | 219 |
|
|
2015
Q2 | $642K | Sell |
3,914
-26,376
| -87% | -$4.21M | 0.03% | 169 |
|
|
2015
Q1 | $4.68M | Sell |
30,290
-5,218
| -15% | -$743K | 0.2% | 102 |
|
|
2014
Q4 | $4.46M | Sell |
35,508
-1,344
| -4% | -$166K | 0.21% | 99 |
|
|
2014
Q3 | $4.41M | Buy |
36,852
+7,002
| +23% | +$803K | 0.23% | 97 |
|
|
2014
Q2 | $3.21M | Sell |
29,850
-1,245
| -4% | -$128K | 0.19% | 103 |
|
|
2014
Q1 | $3.1M | Sell |
31,095
-158
| -0.5% | -$14.3K | 0.21% | 101 |
|
|
2013
Q4 | $2.89M | Buy |
31,253
+5
| +0% | +$444 | 0.22% | 96 |
|
|
2013
Q3 | $2.71M | Buy |
31,248
+664
| +2% | +$56.9K | 0.24% | 87 |
|
|
2013
Q2 | $2.5M | Buy |
+30,584
| New | +$2.29M | 0.26% | 79 |
|
Other funds holding ELV
Morningstar Investment Services's ELV Position: Q1 2025 in Review
Morningstar Investment Services reduced its Elevance Health (ELV) stake by 53% in Q1 2025, selling an estimated $6.33M and leaving 13,982 shares worth $6.08M. The position accounts for 1.11% of the portfolio, ranked #19.
Morningstar Investment Services first reported a position in ELV in Q2 2013 and has held it in 32 quarters since. The position peaked at $239M in Q4 2023. 1,661 funds tracked by Wall St. Rank hold ELV as of Q1 2025.
- Morningstar Investment Services held 13,982 shares of Elevance Health worth $6.08M as of Q1 2025.
- Morningstar Investment Services sold 15,763 Elevance Health shares in Q1 2025, an estimated $6.33M.
- Elevance Health made up 1.11% of Morningstar Investment Services's portfolio in Q1 2025, its #19 holding.
- Morningstar Investment Services first reported a position in Elevance Health in Q2 2013 and has held it in 32 quarters since.
- Morningstar Investment Services's Elevance Health position peaked at $239M in Q4 2023.
- 1,661 funds tracked by Wall St. Rank held Elevance Health as of Q1 2025.
Based on Morningstar Investment Services's 13F filing for Q1 2025, filed 5 May 2025.